Mixed-Lineage Acute Leukemias
Showing 1 - 25 of >10,000
Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia, Mixed-Lineage Acute Leukemias Trial in Saint-Petersburg (Allogeneic stem
Completed
- Leukemia, Acute Lymphoblastic
- +2 more
- Allogeneic stem cell transplantation
- +3 more
-
Saint-Petersburg, Russian FederationFirst Pavlov State Medical University of St. Petersburg
Nov 19, 2020
Leukemia, T Cell Trial in Beijing (CD7 CART)
Recruiting
- Leukemia, T Cell
- CD7 CART
-
Beijing, Hebei, ChinaHe bei Yan da Lu dao pei Hospital
May 24, 2022
Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,
Not yet recruiting
- Acute Myeloid Leukemia
- +10 more
- Ziftomenib
- +4 more
- (no location specified)
Feb 17, 2023
Relapsed/Refractory Leukemias, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia Trial in Kansas City, Cincinnati
Recruiting
- Relapsed/Refractory Leukemias
- +4 more
- SNDX-5613
- +2 more
-
Kansas City, Missouri
- +1 more
Jul 18, 2022
Acute Leukemia, Acute Myeloid Leukemia, MDS Trial in Philadelphia (CliniMACS Cell Processing System for TCRaß + T Cell and
Recruiting
- Acute Leukemia
- +7 more
- CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Mar 21, 2022
Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,
Recruiting
- Acute Bilineal Leukemia
- +7 more
- Clofarabine
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Japan, United States (DSP-5336)
Recruiting
- Leukemia, Myeloid, Acute
- Leukemia, Lymphocytic, Acute
-
Houston, Texas
- +5 more
May 31, 2022
Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia
Not yet recruiting
- Recurrent Acute Leukemia of Ambiguous Lineage
- +5 more
- Biospecimen Collection
- +12 more
- (no location specified)
Mar 8, 2023
Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone
Not yet recruiting
- Acute Myeloid Leukemia With KMT2A Rearrangement
- Acute Myeloid Leukemia With NPM1 Mutation
- Biospecimen Collection
- +7 more
- (no location specified)
Jun 1, 2023
Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,
Not yet recruiting
- Acute Leukemia of Ambiguous Lineage
- +8 more
- Biospecimen Collection
- +12 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 22, 2023
Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage Trial in United States (radiation, drug,
Recruiting
- Acute Biphenotypic Leukemia
- +11 more
- Total-Body Irradiation
- +8 more
-
Los Angeles, California
- +9 more
Aug 19, 2022
The Pediatric Acute Leukemia Screening Trial - A Study to Test
Recruiting
- Recurrent Acute Lymphoblastic Leukemia
- +7 more
- Biospecimen Collection
-
Birmingham, Alabama
- +144 more
Jan 30, 2023
H19 in Acute Lymphoblastic Leukemia.
Not yet recruiting
- Acute Lymphoid Leukemia
- (no location specified)
Jul 11, 2023
Acute Leukemia of Ambiguous Lineage Trial in Suzhou (Venetoclax, azactidine)
Recruiting
- Acute Leukemia of Ambiguous Lineage
-
Suzhou, ChinaThe First Affliated Hospital of Soochow University
Jun 14, 2023
Mixed Phenotype Acute Leukemia (MPAL), Measurable Residual Disease (MRD) Trial in Baltimore (BLINCYTO (Blinatumomab))
Recruiting
- Mixed Phenotype Acute Leukemia (MPAL)
- Measurable Residual Disease (MRD)
- BLINCYTO (Blinatumomab)
-
Baltimore, MarylandGreenebaum Cancer Center at University of Maryland Medical Cente
Apr 18, 2022
Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial (Blinatumomab)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- Mixed Phenotype Acute Leukemia
- (no location specified)
Apr 7, 2022
Kidney Transplant Rejection Trial (MDR-102, Immunosuppressive Agents)
Not yet recruiting
- Kidney Transplant Rejection
- MDR-102
- Immunosuppressive Agents
- (no location specified)
Apr 4, 2022
Non Malignant Diseases, Immunodeficiencies, Hemoglobinopathies Trial in Philadelphia (RIC: Distal Campath, RIC:Intermediate
Recruiting
- Non Malignant Diseases
- +2 more
- RIC: Distal Campath
- +2 more
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Mar 8, 2022
Patients With Acute Leukemia Infected by COVID-19
Completed
- Acute Myeloblastic Leukemia
- +2 more
-
Amiens, France
- +26 more
Jul 26, 2022
Study of miRNA-155 in Acute Leukemia
Not yet recruiting
- Acute Leukemia
- BM aspirate
- (no location specified)
Mar 30, 2023
Relapsed or Resistant Acute Leukaemias Trial in Australia, Taiwan (LBS-007)
Not yet recruiting
- Relapsed or Resistant Acute Leukaemias
-
Adelaide, Australia
- +3 more
Feb 23, 2023
Tumor, Stomach, Gastric Tumors Malignant, Pancreatic Tumors Trial in Bogotá (Petiveria Alliacea Preparation, Placebo)
Not yet recruiting
- Neoplasm, Stomach
- +8 more
- Petiveria Alliacea Preparation
- Placebo
-
Bogotá, ColombiaPontificia Universidad Javeriana
Oct 16, 2022
Mutations and Phenotypes of Unclassifiable Inherited Bone Marrow
Recruiting
- Inherited BMF Syndrome
- The whole-exome sequencing
-
Sohag, Egypt, Faculty of Medicine, Sohag University
Jun 28, 2022